Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.286EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.286EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.369EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.15EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.236EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.236EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.153EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.302EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.302EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.194EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.194EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.436EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.436EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.558EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.558EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.518EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.518EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.368EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.368EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.404EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.404EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.240.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.240.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.121.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-1649.2South Korea
AY.121.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-2445.63South Korea
B.1.1.46EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.389EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.389EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.270EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.270EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.227EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.227EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used